Clinical Trial Update: Interest of Mycophenolate for CIDP Weaning [Phase 3]

View source ↗

Summary

Phase 3 trial assessing mycophenolate for weaning in Chronic Inflammatory Demyelinating Polyradiculopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyradiculopathy

Drugs mentioned

• MycoPhenolate (mycophenolate mofetil)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Chronic Inflammatory Demyelinating Polyradiculopathy | Phase 3 | Status: COMPLETED